PFKP Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-32083
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1.0 mg/ml
Product Summary for PFKP Antibody
Immunogen
The immunogen this antibody was made to, maps to a region between residue 375 to 425 of human Phosphofructokinase, Platelet using the numbering given in entry NP_002618.1 (GeneID 5214).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PFKP Antibody
Immunoprecipitation: PFKP Antibody [NBP2-32083]
Immunoprecipitation: PFKP Antibody [NBP2-32083] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from 293T cells. Antibodies: Affinity purified rabbit anti-PFKP antibody NBP2-32083 used for IP at 6 ug per reaction. For blotting immunoprecipitated PFKP was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.Applications for PFKP Antibody
Application
Recommended Usage
Immunoprecipitation
2 - 10 ug/mg lysate
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: PFKP
Alternate Names
6-phosphofructokinase type C, 6-phosphofructokinase, platelet type, EC 2.7.1, EC 2.7.1.11, PFK-CFLJ40226, PFKFplatelet type, Phosphofructokinase 1, phosphofructokinase, platelet, phosphohexokinase
Gene Symbol
PFKP
UniProt
Additional PFKP Products
Product Documents for PFKP Antibody
Product Specific Notices for PFKP Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...